The pathophysiology of chronic cardiorenal disease based on central hemodynamics
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2018, Vol 5, Issue 3
Abstract
As patients with chronic kidney disease (CKD) and chronic heart failure (CHF) increase, there is concern about a future heart failure pandemic. Deterioration of renal function is an independent prognostic factor for CHF after decongestion. Interactions between renal disease and cardiac disease are increasing, including nephrosclerosis and heart failure with preserved ejection fraction (HFpEF), which are both derived from augmentation of central pulse pressure by age-related arterial stiffening. Thus, it is necessary to treat multiple underlying diseases of cardiorenal syndrome simultaneously. However, an effective therapeutic strategy for HFpEF has not been established. This review reconsiders the pathophysiology of chronic cardiorenal disease related to arterial stiffening from the viewpoint of central hemodynamics and explores treatment options.
Authors and Affiliations
Ohno Michiya
Keywords
Related Articles
- EP ID EP523817
- DOI 10.17352/2455-2976.000067
- Views 87
- Downloads 0
Echocardiographic Biatrial Remodelling and Diastolic Function Assessment in Long-Term Follow-Up after Typical Atrial Flutter Ablation
Background: A reverse left atrial (LA) remodelling after atrial fibrillation (AF) ablation has been reported and a relationship between diastolic function and AF is well known. However, there is little information about...
Can Strict Control of Renalase Present a New Treatment Alternative in Regulating Blood Pressure?
Blood pressure is the pressure the blood in arteries applies on vessels. Abnormal blood pressure is a major public health problem commonly encountered in the population with normal blood pressure and intensive care patie...
Complications of a Fenestrated Endovascular Aortic Aneurysm Repair (EVAR): A case study and first experience of National Institute of Cardiovascular Diseases Hospital, Dhaka
Endovascular aneurysm repair (EVAR) has revolutionized the therapeutic strategy for abdominal aortic aneurysm (AAA). However, hostile proximal neck and tortousity of access remain a challenge in selecting optimal stent g...
How the New International recommendation for Electrocardiographic interpretation in Athletes would change our practice
Recent evidences in the prevention of sudden cardiac death (SCD) confirmed the importance of pre-participation cardiovascular screening in athletes to early identify, and further disqualify from the competition, all the...
Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
Background: We compared the angiotensin receptor–neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction. Methods: In this double-...